AlphaFold predicted structure
CHRNA2 · Q15822

Mean pLDDT
77.0/ 100
Confident
529 residues
Confidence breakdown
- Very high(≥ 90)49%
- Confident(70–90)26%
- Low(50–70)2%
- Very low(< 50)24%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cholinergic receptor nicotinic alpha 2 subunit
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownautosomal dominant nocturnal frontal lobe epilepsy
familial sleep-related hypermotor epilepsy
sleep-related hypermotor epilepsy
benign familial infantile epilepsy
chronic obstructive pulmonary disease
cervical carcinoma
lung cancer
Alzheimer disease
pulmonary emphysema
rheumatic disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Neuronal acetylcholine receptor subunit alpha-2
Component of neuronal acetylcholine receptors (nAChRs) that function as pentameric, ligand-gated cation channels with high calcium permeability among other activities. nAChRs are excitatory neurotrasnmitter receptors formed by a collection of nAChR subunits known to mediate synaptic transmission in the nervous system and the neuromuscular junction. Each nAchR subunit confers differential attributes to channel properties, including activation, deactivation and desensitization kinetics, pH sensitivity, cation permeability, and binding to allosteric modulators (PubMed:18723036). CHRNA2 forms heteropentameric neuronal acetylcholine receptors with CHRNB2 and CHRNB4 and plays a role in nicotine dependence (PubMed:24467848, PubMed:27493220)
CHRNA2 · Q15822

Mean pLDDT
77.0/ 100
Confident
529 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0